May 13, 2024 Experience AC Immune exclusive option and license agreement with Takeda Pharmaceuticals We advised AC Immune on the transaction
May 3, 2024 Experience Uniti Group merger with Windstream We are advising Uniti Group on the transaction
April 24, 2024 Experience Lightyear GP-led secondary transaction and formation of continuation fund We advised Lightyear on the secondary transaction and continuation fund formation
April 1, 2024 Experience Nuvei $6.3 billion going-private acquisition We are advising Nuvei on the transaction
March 11, 2024 Experience TASK Group Holdings AU$310 million acquisition by PAR Technology We are advising TASK on the transaction
February 16, 2024 Experience HireRight $1.65 billion acquisition by General Atlantic and Stone Point Capital We are advising the special committee of HireRight on the transaction
February 9, 2024 Experience Owens Corning $3.9 billion acquisition of Masonite International We are advising Owens Corning on the acquisition
February 5, 2024 Experience Novo Nordisk acquisition of certain Catalent sites from Novo Holdings We are advising Novo Nordisk on the acquisition
January 26, 2024 Experience Bridgepoint sale of a minority interest in Humanetics We are advising Bridgepoint and Humanetics on the transaction